J Korean Child Neurol Soc.
2018 Mar;26(1):1-6. 10.26815/jkcns.2018.26.1.1.
Intravenous Immunoglobulin in the Treatment of Neurological Diseases
- Affiliations
-
- 1Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea. ymleemd@yuhs.ac
- KMID: 2435266
- DOI: http://doi.org/10.26815/jkcns.2018.26.1.1
Abstract
- Intravenous immunoglobulin (IVIG) is used in treating many cases of autoimmune and inflammatory conditions thanks to its multiple anti-inflammatory and immunomodulatory properties. The clinical use of IVIG has been for the patients with primary immunodeficiencies, but lately it is expanding its usage to the realms of treating patients with neurological conditions. Both the efficacy and safety of IVIG treatment in chronic inflammatory demyelinating polyradiculoneuropathy and Guillain-Barré syndrome have been studied successfully. However, the use of IVIG treatment in other neurological conditions still remains investigational despite several successful reports. Considerable numbers of mechanisms have been suggested in order to explain the effects of IVIG, but the exact mechanisms are not understood yet. This review covers the new developments in clinical fields and the possible ways in which IVIG could help in the future.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case of Cerebral Infarction Following Intravenous Immunoglobulin Therapy in a Patient with Guillain-Barre Syndrome
- Pulmonary Thromboembolism after Intravenous Immunoglobulin Therapy in Guillain-Barre Syndrome
- Intravenous Immunoglobulin Therapy in Guillain-Barre Syndrome
- Intravenous immunoglobulin for patients with repeated failure of in vitro fertilization-embryo transfer
- The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?
